Navigation Links
BioParadox Announces Partnership with Fogarty Institute for Innovation
Date:2/2/2012

MENLO PARK, Calif., Feb. 2, 2012 /PRNewswire/ -- BioParadox, Inc., a regenerative medicine company pioneering point-of-care biologic treatments for cardiovascular disease, today announced a strategic alliance with Fogarty Institute for Innovation. 

"We are delighted to begin working with the Fogarty Institute for Innovation known for its commitment to developing creative solutions for patients with challenging problems.  The Fogarty Institute's unique programs to support medical innovators by providing important business, technical, and clinical input offers BioParadox the opportunity to rapidly advance its novel Platelet-Cell Therapy (PCT) for the treatment of cardiovascular disease," said Allan Mishra, MD, Founder of BioParadox. 

Speaking at the January 2012 Conference on Cell Therapy for Cardiovascular Disease in New York, Todd Brinton, MD, presented data supporting PCT for peripheral vascular disease.  BioParadox was also recently awarded a United States patent covering this technology. 

About BioParadox

BioParadox is innovating the use of Platelet-Cell Therapy (PCT) for the treatment of cardiovascular disease. The company's first products, VitaKine® and RevaTen®, are proprietary formulations that have been shown to enhance cardiovascular function. They are produced exclusively by BioParadox.

For more information, please visit: BioParadox.com or e-mail: info@bioparadox.com

About the Fogarty Institute for Innovation

The Fogarty Institute for Innovation is an educational 501(c) (3) non-profit committed to the mission of improving patient care by supporting revolutionary medical innovation. The Institute offers promising innovators world-class technical and business mentoring, laboratory space, and clinical support to propel medical innovations from conception to application. Further information is available at www.fogartyinstitute.org.


'/>"/>
SOURCE BioParadox, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Regenerative Medicine Company BioParadox adds Healthcare and Medical Device Expert, Michael Kleine, to its Board of Directors
2. Hybrid Fuels, Inc. Announces FDA Approved Lab Selection for Azul Instant™ - "Be Ready in an Instant"
3. Nautilus Neurosciences Announces New Patent Issued
4. Boston Scientific Announces First Implant and Market Launch of PROMUS Element™ Plus Stent System in Europe
5. Sapio Sciences Announces Exemplar Dx LIMS for Laboratories in the Burgeoning MDx Market
6. Medical Alarm to Begin Fulfillment of MediPendant™ Against Largest Purchase Order - Announces Additional Warrant Cancellations
7. RemedyMD Announces Investigate Cell Therapy, a Revolutionary Research Management System for Blood and Marrow Transplant Centers
8. China Health Resource Announces Professor Liang Li, World Renowned TCM Expert, to Lead Gastrodia Deep Processing Research
9. Amsterdam Molecular Therapeutics Announces European Commission Delays Decision on Glybera® Marketing Authorisation and Requests Further Information From the CHMP
10. IDEXX Laboratories Announces Fourth Quarter and Full Year Results
11. Oclaro Announces Second Quarter Fiscal Year 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/18/2017)... CAMBRIDGE, Mass. , Jan. 18, 2017  Tarix ... Drug Administration has granted a Rare Pediatric Disease (RPD) ... treatment of Recessive Dystrophic Epidermolysis Bullosa (RDEB), a rare ... for RDEB and treatment is limited to supportive care. ... supplements the Orphan Drug Designation previously granted by the ...
(Date:1/18/2017)... Jan. 18, 2017  Robust competition in the ... discounts on medicine prices, according to a new ... study is among the first to examine the share ... manufacturers, pharmacy benefit managers (PBMs), health plans and other ... study is the first to show what happens when ...
(Date:1/17/2017)... NEW YORK , Jan. 17, 2017 ... Summary GlobalData,s new report, "North America Insulin Delivery ... the North America Insulin Delivery market. The report provides ... and average prices (USD) within market segments - Insulin ... Accessories. The report also provides company shares and ...
Breaking Medicine Technology:
(Date:1/18/2017)... (PRWEB) , ... January 18, 2017 , ... Floundering on ... Heart Month and the perfect time for a reset. The U.S. Apple Association agrees ... to combat many of the factors that contribute to heart disease. , The U.S. ...
(Date:1/17/2017)... ... , ... For breast cancer clinicians and researchers who were unable to attend ... intimate review and analysis of its highlights, a novel half-day, complimentary meeting—the 14th Annual ... on February 4, 2017 in Chicago. Chaired by Kathy S. Albain, MD, FACP, FASCO ...
(Date:1/17/2017)... ... January 17, 2017 , ... Etymotic ... National Association of Music Merchants (NAMM) winter trade show, Booth #2876, at the ... ER•4® has long been the gold standard for high-definition, in-ear earphones. This classic ...
(Date:1/17/2017)... ... January 17, 2017 , ... Peoples Health is pleased to ... on Dec. 1, 2016. Peoples Health, a Metairie-based Medicare Advantage company, serves more ... addition to our provider network, and the addition will benefit our members in ...
(Date:1/17/2017)... ... January 17, 2017 , ... ... planning assistance to families and business professionals throughout central Colorado, is joining local ... families. , The Aurora Warms The Night organization is committed to breaking the ...
Breaking Medicine News(10 mins):